Skip to main content
TipRanks
Go Ultimate75% OFF

Bayer (BAYRY) Revenue by Segment

2,118 Followers

Revenue by Segment

In Q2 2026, Bayer reported revenue by segment of €59.00M (Other), €4.91B (Crop Science), €4.46B (Pharmaceutical) and €1.45B (Consumer Health).

Shows how different business units contribute to overall sales, highlighting strengths, diversification, and areas of growth or concern within the company’s operations.

€0.00€2.50B€5.00B€7.50B€10.00B€12.50B€15.00BMar 21Jun 21Sep 21Dec 21Mar 22Jun 22Sep 22Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26
Chart Insights

Bayer's Crop Science segment shows a cyclical pattern with peaks in Q1, but a gradual decline in peak values since 2022 suggests potential market saturation or competitive pressures. The Pharmaceutical segment remains stable, indicating resilience despite broader economic challenges. Consumer Health exhibits modest growth, hinting at increased demand for health products. Without new earnings call insights, the focus should be on Crop Science's strategic adjustments to regain momentum and capitalize on Consumer Health's steady growth.

BAYRY Revenue by Segment

PeriodOtherCrop SciencePharmaceuticalConsumer Health
Q2 2026Jun 30, 2026€59.00M€4.91B€4.46B€1.45B
Q1 2026Mar 31, 2026€107.00M€7.56B€4.25B€1.49B
Q4 2025Dec 31, 2025€105.00M€5.40B€4.48B€1.46B
Q3 2025Sep 30, 2025€52.00M€3.86B€4.33B€1.42B
Q2 2025Jun 30, 2025€54.00M€4.79B€4.47B€1.43B
Q1 2025Mar 31, 2025€111.00M€7.58B€4.55B€1.50B
Q4 2024Dec 31, 2024€119.00M€5.38B€4.66B€1.57B
Q3 2024Sep 30, 2024€59.00M€3.99B€4.51B€1.41B
Q2 2024Jun 30, 2024€100.00M€4.98B€4.61B€1.46B
Q1 2024Mar 31, 2024€68.00M€7.91B€4.36B€1.43B
Q4 2023Dec 31, 2023€75.00M€5.63B€4.58B€1.58B
Q3 2023Sep 30, 2023€29.00M€4.37B€4.54B€1.41B
Q2 2023Jun 30, 2023€97.00M€4.92B€4.56B€1.47B
Q1 2023Mar 31, 2023€58.00M€8.35B€4.41B€1.57B
Q4 2022Dec 31, 2022€52.00M€5.57B€4.86B€1.52B
Q3 2022Sep 30, 2022€86.00M€4.69B€4.96B€1.55B
Q2 2022Jun 30, 2022€44.00M€6.46B€4.82B€1.50B
Q1 2022Mar 31, 2022€56.00M€8.45B€4.62B€1.51B
Q4 2021Dec 31, 2021€72.00M€4.69B€4.95B€1.41B
Q3 2021Sep 30, 2021€46.00M€3.85B€4.54B€1.35B
Q2 2021Jun 30, 2021€49.00M€5.02B€4.49B€1.29B
Q1 2021Mar 31, 2021€65.00M€6.65B€4.37B€1.25B
Q4 2020Dec 31, 2020€93.00M€4.18B€4.48B€1.25B
Q3 2020Sep 30, 2020€44.00M€3.03B€4.23B€1.21B
Q2 2020Jun 30, 2020€59.00M€4.80B€3.99B€1.20B
Q1 2020Mar 31, 2020€67.00M€6.83B€4.55B€1.40B
Q4 2019Dec 31, 2019€79.00M€4.65B€4.68B€1.34B
Q3 2019Sep 30, 2019€90.00M€3.95B€4.50B€1.29B
Q2 2019Jun 30, 2019€61.00M€4.79B€4.42B€1.44B
Q1 2019Mar 31, 2019€59.00M€6.44B€4.35B€1.40B

Related KPIs